Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study

Xiaocong Li Marston(Shanghai Open University), Martin Unverdorben(Daiichi Sankyo (United States)), Lisa Zimmermann(University Medical Center Freiburg), Bernd Brüggenjürgen(Charité - Universitätsmedizin Berlin), Xīn Gào(Qingdao University), X. Ye(Daiichi Sankyo (United States)), Yu‐Chen Yeh(Abt Global (United States)), R. Wang(North Sichuan Medical University)
International Journal of Cardiology
November 12, 2021
Cited by 35


Related Papers